Amazing work! Congratulations!
16.10.2025 23:00 β π 1 π 0 π¬ 0 π 0@andriigorelik.bsky.social
Sir Henry Wellcome Fellow | Oxford with Ivan Ahel & Harvard with Steve Gygi Molecular mechanisms of cysteine modifications | GlcNAc and ADP-ribose Previously: The Francis Crick Institute/Imperial College London (postdoc), University of Dundee (PhD)
Amazing work! Congratulations!
16.10.2025 23:00 β π 1 π 0 π¬ 0 π 0Online now! CBX4 acetoacetylation as an inhibitory mechanism of HIF-1Ξ± activity #chembiol
07.10.2025 15:30 β π 4 π 1 π¬ 0 π 0Out in @natcomms.nature.com: Cryo-EM structure of the pseudo-HAT-containing O-GlcNAcase! 
Especially exciting since multiple companies are developing O-GlcNAcase inhibitors for Alzheimer's disease (tau is O-GlcNAcylated). Glad to have a small contribution in this story.
Congrats to all authors!
Historically, viruses were thought to primarily use host cell's translational machinery. New work from @harvardcellbio.bsky.social faculty Amy Lee reveals that a giant DNA virus encodes its own IF4F initiation complex, suggesting an unexpected evolutionary innovation. www.biorxiv.org/content/10.1...
02.10.2025 18:10 β π 93 π 39 π¬ 0 π 2New work from our own Chouchani Lab finds that LRRC58 is the substrate adaptor of an E3 ubiquitin ligase that mediates proteasomal degradation of CDO1, the rate-limiting enzyme of the catabolic shunt of cysteine to taurine in response to altered Cysteine levels. www.nature.com/articles/s41...
17.09.2025 17:48 β π 11 π 4 π¬ 0 π 1Robert Redford (RIP) survived a childhood bout of polio though bedridden for 2 weeks
In 2014, he directed a short film on the architecture and mission of La Jolla's Salk Instituteβhonoring founder Jonas Salk, inventor of the polio vaccine that has saved countless lives, and architect Louis Kahn
A few years back we discovered a dual hybrid protein modification composed of an ADP-ribose dinucleotide and the ubiquitin moieties (ADPr-Ub). Here you can read our review that will give you an update on this increasingly popular topic:
rdcu.be/eETIT
Delighted to share our work on cellular ubiquitination of drug-like compounds by HUWE1 - a surprising journey! Kudos to all contributors & first authors, Barbara Orth and Pavel Pohl. Sincere thanks to @ireserra.bsky.social β¬ #NatCommun for expertly guiding the winding publishing path.
rdcu.be/eDzPk
Are you a postdoc interested in the mechanisms of disease?
Do you have a great record and an exciting vision?
Come and start your own lab @dunnschool.bsky.social by applying for sponsorship for early career fellowships.
Deadline 30th September...pass it on!
www.path.ox.ac.uk/work-with-us...
Congratulations to first authors Gregor Lueg, James Zhang, Monica Faronato and big thanks to all co-authors for being amazing colleagues and collaborators! 
Special thanks to Ed Tate and Dinis Calado for supervising this exciting project!
Finally, we show that an orally bioavailable NMTi eliminates MYC-deregulated tumours in vivo without overt toxicity. MYC oncogene is deregulated in >50% of cancers but is notoriously difficult to target. Our discovery of the MYC-NMTi synthetic lethality circumvents this obstacle.
28.08.2025 15:22 β π 0 π 0 π¬ 1 π 0Fortuitously, we discover that a patient mutation in NDUFAF4, associated with a neurological disorder called the Leigh syndrome, also leads to loss of myristoylation on NDUFAF4, its degradation and therefore dysfunctional respiratory complex I.
28.08.2025 15:22 β π 0 π 0 π¬ 1 π 0Mechanistically, NMTi-induced mitochondrial failure is concurrent with loss of myristoylation on respiratory complex I assembly factor NDUFAF4 with its subsequent proteasomal degradation via the glycine N-degron mechanism.
28.08.2025 15:22 β π 0 π 0 π¬ 1 π 0Using proteomics, we discovered that NMTi cause mitochondrial dysfunction (complex I defects) in high-MYC cancer cells.
28.08.2025 15:22 β π 0 π 0 π¬ 1 π 0We screened hundreds of cancer cell lines using a potent and selective N-myristoyltransferase inhibitor (NMTi) and found a strong correlation between increased NMTi sensitivity and MYC deregulation with death of high (vs low) MYC cancer cells.
28.08.2025 15:22 β π 0 π 0 π¬ 1 π 0Happy to share that my first-author paper from my postdoc at Imperial @imperialcollegeldn.bsky.social and The Francis Crick Institute @crick.ac.uk is now published in Cell Reports!
www.sciencedirect.com/science/arti...
Want to know how lipidation of some nascent chains takes place by NMT2-- Check our latest work on how NAC couples Protein Synthesis with Nascent Polypeptide Myristoylation on the Ribosome out today @embojournal.orgβ¬: www.embopress.org/doi/full/10....
26.08.2025 11:00 β π 42 π 21 π¬ 2 π 2Excited to share a new preprint from the lab. We show that PTMs like phosphorylation & glycosylation dynamically reshape proteome-wide ligandability in cells, including proteins like KRAS. Great collaboration with the Huang Lab, @forlilab.bsky.social and BMS. www.biorxiv.org/content/10.1...
03.08.2025 14:36 β π 80 π 24 π¬ 0 π 1I still canβt believe that all NIH grants to my colleagues at Harvard and Harvard Medical School have been nullified. And that, as a nation, weβre somehow okay with this illegal, arbitrary, and petty act. Just think of the consequences: scientists, students, and patients will all suffer.
18.07.2025 03:30 β π 560 π 187 π¬ 18 π 11A few years back we discovered a dual hybrid protein modification composed of ADP-ribose dinucleotide and ubiquitin (ADPr-Ub). Now we reveal that ADPr-Ub can be further ubiquitinated by the E3 ubiquitin ligase RNF114!
www.nature.com/articles/s41...
www.science.org/doi/10.1126/...
An amazing paper from van der Heden and Ahel groups! They use clever chemistry to identify RNF114 as a dual ADP-ribose-Ubiquitin reader involved in the DNA damage response! Congratulations to first authors Max, @chatrin-c.bsky.social and Rishov. Happy to have a small contribution in this story
10.07.2025 10:44 β π 17 π 5 π¬ 0 π 0This is wild! 
Engineering E. coli bacteria to turn plastic waste into paracetamol (Tylenol) 
www.nature.com/articles/s41...
www.nature.com/articles/s41...
A few years back we discovered a novel dual hybrid protein modification composed of ADP-ribose dinucleotide and ubiquitin (ADPr-Ub):
pubmed.ncbi.nlm.nih.gov/36197986/
Big thanks to all co-authors at FGC in Cambridge, Hull, Oslo, NCI Frederick and of course @ahellab.bsky.social @dunnschool.bsky.social! I had a lot of fun doing proteomics in Steve Gygiβs lab @harvardcellbio.bsky.social funded by Sir Henry Wellcome Fellowship - thanks to @wellcometrust.bsky.social!
11.06.2025 12:54 β π 0 π 0 π¬ 0 π 0Plus, our CRISPR screen identified SOCS3 knockout as a new synthetic lethal interaction with PARP7i. Curiously, SOCS3 is also linked to AHR signalling.
11.06.2025 12:47 β π 0 π 0 π¬ 1 π 0Transcriptomics is typically used to study transcription factors, but we took a different approach β examining proteome changes following PARP7 inhibition and AHR activation. This revealed post-translational events that contribute to the synthetic lethality via combined PARP7i and AHR activation.
11.06.2025 12:47 β π 0 π 0 π¬ 1 π 0New paper! We uncover mechanistic insights into the crosstalk between AHR (aryl hydrocarbon receptor, a transcription factor) and PARP7 (a nuclear enzyme that performs protein ADP-ribosylation). Both are promising cancer drug targets.
Big thanks to all co-authors!
www.pnas.org/doi/10.1073/...
We have another postdoc position available to work on interplay between ADP-ribosylation and ubiquitination in regulation of genome stability. For this post expertise in cell biology is required.
my.corehr.com/pls/uoxrecru...
A postdoc position is available in our lab to study ADP-ribosylation and ubiquitylation signalling! We are looking for someone with experience in structural biology and biochemistry. The application deadline is June 20th.
my.corehr.com/pls/uoxrecru...
New work @harvard by Miguel Gonzalez-Lozano @harperlabhms.bsky.social & @ernstschmid.bsky.social in Johannes Walter lab charts structural interactome of endosomes. #XL-MS #Alphafold Funded by @asapresearch.parkinsonsroadmap.org & NIH. Science continues-despite attacks www.nature.com/articles/s41...
28.05.2025 15:52 β π 44 π 19 π¬ 0 π 1